Brakenhoff RH - Search Results

1

The molecular landscape of head and neck cancer.

Leemans CR, Snijders PJF, Brakenhoff RH. Leemans CR, et al. Among authors: brakenhoff rh. Nat Rev Cancer. 2018 May;18(5):269-282. doi: 10.1038/nrc.2018.11. Epub 2018 Mar 2. Nat Rev Cancer. 2018. PMID: 29497144 Review.

2

Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer.

Brakenhoff RH, van Gog FB, Looney JE, van Walsum M, Snow GB, van Dongen GA. Brakenhoff RH, et al. Cancer Immunol Immunother. 1995 Mar;40(3):191-200. doi: 10.1007/BF01517351. Cancer Immunol Immunother. 1995. PMID: 7728778 Free PMC article.

3

The feasibility of radioimmunotherapy of head and neck cancer.

Gerretsen M, Quak JJ, Brakenhoff RH, Snow GB, van Dongen GA. Gerretsen M, et al. Among authors: brakenhoff rh. Eur J Cancer B Oral Oncol. 1994;30B(2):82-7. doi: 10.1016/0964-1955(94)90057-4. Eur J Cancer B Oral Oncol. 1994. PMID: 8032305

4

Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform.

Van Hal NL, Van Dongen GA, Rood-Knippels EM, Van Der Valk P, Snow GB, Brakenhoff RH. Van Hal NL, et al. Among authors: brakenhoff rh. Int J Cancer. 1996 Nov 15;68(4):520-7. doi: 10.1002/(SICI)1097-0215(19961115)68:4<520::AID-IJC19>3.0.CO;2-8. Int J Cancer. 1996. PMID: 8945625 Free article.

5

Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines.

Braakhuis BJ, Klaassen I, van der Leede BM, Cloos J, Brakenhoff RH, Copper MP, Teerlink T, Hendriks HF, van der Saag PT, Snow GB. Braakhuis BJ, et al. Among authors: brakenhoff rh. Br J Cancer. 1997;76(2):189-97. doi: 10.1038/bjc.1997.361. Br J Cancer. 1997. PMID: 9231918 Free PMC article.

6

All-trans retinoic acid induced gene expression and growth inhibition in head and neck cancer cell lines.

Copper MP, Klaassen I, Brakenhoff RH, Cloos J, Snow GB, Braakhuis BJ. Copper MP, et al. Among authors: brakenhoff rh. Oral Oncol. 1997 Jul;33(4):270-4. doi: 10.1016/s0964-1955(97)00024-9. Oral Oncol. 1997. PMID: 9307717

7

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.

van Gog FB, Brakenhoff RH, Stigter-van Walsum M, Snow GB, van Dongen GA. van Gog FB, et al. Among authors: brakenhoff rh. Int J Cancer. 1998 Jul 3;77(1):13-8. doi: 10.1002/(sici)1097-0215(19980703)77:1<13::aid-ijc3>3.0.co;2-2. Int J Cancer. 1998. PMID: 9639387 Free article.

8

Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction.

Brakenhoff RH, Stroomer JG, ten Brink C, de Bree R, Weima SM, Snow GB, van Dongen GA. Brakenhoff RH, et al. Clin Cancer Res. 1999 Apr;5(4):725-32. Clin Cancer Res. 1999. PMID: 10213205

9

Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.

van Hal NL, van Dongen GA, Stigter-van Walsum M, Snow GB, Brakenhoff RH. van Hal NL, et al. Among authors: brakenhoff rh. Int J Cancer. 1999 Sep 9;82(6):837-45. doi: 10.1002/(sici)1097-0215(19990909)82:6<837::aid-ijc12>3.0.co;2-h. Int J Cancer. 1999. PMID: 10446451 Free article.

10

Minimal residual disease in head and neck cancer.

Gath HJ, Brakenhoff RH. Gath HJ, et al. Among authors: brakenhoff rh. Cancer Metastasis Rev. 1999;18(1):109-26. doi: 10.1023/a:1006268621730. Cancer Metastasis Rev. 1999. PMID: 10505550 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

238 results

Search Page